Artificial Intelligence in Mammography Screening in Norway
Recruiting · NCT06032390 · Interventional (participants receive a specific treatment) · Lead sponsor: Norwegian Institute of Public Health
View the official record on ClinicalTrials.gov →Interventions studied
AI assisted mammography screening interpretationStandard mammography screening interpretation
What this trial is about
The purpose of this randomized controlled trial is to compare the number of breast cancers detected among women who had their screening mammograms interpreted by artificial intelligence (AI) in combination with one or two breast radiologists to the number of breast cancers detected after standard independent double reading in BreastScreen Norway. The aims of the study is to prove that screening interpretation with AI in combination with one or two radiologists (the intervention) is non-inferior to standard interpretation procedure.
Who can take part
Age range
50 Years to 69 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Women attending the population-based mammography screening program BreastScreen Norway providing a signed, informed consent
Exclusion criteria
- Women attending the population-based mammography screening program BreastScreen Norway not providing a signed, informed consent
Where it is running
1 location listed.
- Cancer Registry of Norway, Norwegian Institute of Public Health - Oslo, Norway